From Gay Man to Transwoman... and Back Again | Michael Kerr
25 June 2026
With Michael Kerr
detransition
Michael Kerr's story — from gay man to transwoman and back — traces a pattern of institutional failure. His experience with the NHS reveals a system captured by gender-identity ideology that failed to treat underlying trauma, then abandoned him when he chose to detransition. His founding of Detransition Pathway UK is both a personal response and an indictment of how far formal medicine has drifted from its duty of care.
Michael Kerr is a Scottish man who transitioned to living as a woman and later detransitioned. He is the founder of Detransition Pathway UK, a peer-to-peer support organisation for people navigating their way out of a gender transition. His story has a familiar emotional architecture — early trauma, an institutional system that treated identity claims as clinical answers, a long and difficult process of finding his way back — but he tells it with a candour that makes the structural failures hard to ignore. The episode examines how unresolved trauma shaped Michael's path toward transition. This is a pattern that recurs in critical discussions of gender medicine: the question of whether distress rooted in adverse experience is being correctly identified and addressed, or whether it is being re-labelled and medically managed in ways that bypass the psychological work required. For Michael, the GP referral process began a chain of clinical encounters that, by his account, never adequately examined what lay beneath his gender-related distress. What emerges from his account of the NHS is a picture of an institution that had reorganised its practices in this domain around affirmation rather than assessment. Suicide threats, he says, were not treated as psychiatric emergencies warranting deeper investigation but as leverage in a pathway that moved in one direction. The Sandyford clinic features in his account, and the culture he describes raises questions about what happens when a public health institution internalises an ideological framework rather than maintaining clinical neutrality. Detransition brought a second encounter with institutional indifference. The same NHS that had facilitated his transition offered little when he sought help processing what had happened or addressing its physical effects. This asymmetry — swift action in one direction, near-total neglect in the other — is one of the more damaging features of the current system. It suggests that the infrastructure built around gender-affirming care has not been matched by any equivalent provision for those who find it was the wrong path. Michael's response has been to build what did not exist for him. Detransition Pathway UK is a peer-led organisation offering practical help and human connection to detransitioners who are otherwise navigating a process invisible to the medical and political systems that enabled their original transitions. Its existence is itself a comment on how thoroughly the needs of this population have been overlooked, and how completely the public conversation has been structured around one set of outcomes. His account is a case study in what happens when institutions trade clinical rigour for ideological coherence. The Beyond Gender hosts bring psychotherapeutic, research-based, and psychological perspectives to a story that illuminates not just individual harm but systemic dysfunction. At a moment when gender medicine is under increasing scrutiny, testimony from detransitioners offers something policy debates often lack: a close-range view of the gap between what gender-affirming systems promise and what they actually deliver.
